| abstract |
The invention includes the use of activity reducing agentsnEffectors of Dipeptidyl Peptidase (DP IV-) or DPnIV analog enzyme activity in a mammalian blood to lower itnof blood sugar levels in mammalian organisms.n n n Effectors used according to the invention are e.g. DP IV inhibitors likenthe dipeptide derivatives or dipeptide mimetics alanyl pyrolidide,nIsoleucyl thiazolidide and the pseudosubstrate N-valyl-prolyl, O-benzoylnHydroxylamine or its salts, especially its fumarates. |